Close

UTHR Financial Facts

Operating income: 238.6M
Cost of product sales: 23.6M
See Full Income Statement

Accumulated other comprehensive loss: -16.8M
Marketable investments: 79.6M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date 5/1/24 EPS Growth Rate +18.9%
Average EPS % Beat Rate +6.1% Revenue Growth Rate +22.7%
Average % Move 1-Wk after EPS -0.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/1/24 Q124 N/A$5.78 N/A N/A$621.93M N/A N/A N/A
2/21/24 Q423 $4.36$4.44 -$0.08$614.7M$575.1M N/A Details
11/1/23 Q323 $5.38$5.15 +$0.23$609.4M$587.9M N/A Details
8/2/23 Q223 $5.24$4.57 +$0.67$596.5M$524.18M N/A Details
5/3/23 Q123 $4.86$4.54 +$0.32$506.9M$512.69M N/A Details
2/22/23 Q422 $2.67$4.72 -$2.05$491.5M$519.21M N/A Details
11/2/22 Q322 $4.91$4.06 +$0.85$516M$493.81M N/A Details
8/3/22 Q222 $2.41$4.38 -$1.97$466.9M$460.67M N/A Details